Ensera

Ensera

Warsaw, Poland· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.5M

Overview

Ensera is a Poland-based, global medical and pharmaceutical device design and contract manufacturing expert, founded in 2019. The company operates as a full-service CDMO, offering capabilities spanning research, human factors, industrial design, engineering, electronics, software, prototyping, and GMP manufacturing with cleanroom, packing, and sterilization management. With facilities in Europe, the US, and Asia, Ensera focuses on complex, sterile, and regulated products, positioning itself as a flexible partner for accelerating time-to-market in the combination product and advanced medical device sectors.

Medical DevicesDrug Delivery

Technology Platform

Integrated service platform for medical device and combination product design, engineering, and manufacturing. Capabilities span user research, human factors, industrial design, electronics/software engineering, prototyping, GMP manufacturing, sterile barrier systems, cleanroom packing, kitting, and sterilization management.

Funding History

1
Total raised:$1.5M
Seed$1.5M

Opportunities

The growing market for biologic drug delivery and combination products drives demand for integrated design and manufacturing expertise.
Additionally, trends toward supply chain regionalization and outsourcing of complex, sterile manufacturing present significant expansion opportunities for a global CDMO with Ensera's capabilities.

Risk Factors

Key risks include customer concentration dependency on a few large clients, severe operational and regulatory risks associated with sterile medical device manufacturing, and intense competition in the CDMO space which could pressure pricing and margins.

Competitive Landscape

Ensera competes in a fragmented global CDMO market against large players like Flex, Jabil, and Sanmina, as well as specialized medical device manufacturers and packaging firms. Its differentiation lies in its integrated end-to-end service model, deep sector focus, and global sterile processing capabilities.